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Abstract A serum free medium was developed for
the production of recombinant antibody against
Botulinum A (BoNTA) using dihydrofolate reductase
deficient Chinese Hamster Ovary Cells (CHO-DG44)
in suspension culture. An initial control basal
medium was prepared, which was similar in compo-
sition to HAM’s F12: IMDM (1:1) supplemented
with insulin, transeferrin, selenium and a lipid
mixture. The vitamin concentration of the basal
medium was twice that of HAM’s F12: IMDM (1:1).
CHO-DG44 cells expressing S25 antibody grew from
2 · 105 cells to maximum cell density of
1.04 · 106 cells/ml after 5 days in this control
medium. A central composite design was used to
identify optimal levels and interaction among five
groups of medium components. These five groups
were glutamine, Essential Amino Acids (EAA), Non
Essential Amino Acids (NEAA), Insulin, Transferrin,
Selenium (ITS), and lipids. Fifty experiments were
carried out in four batches, with two controls in each
batch. There was little effect of ITS and Lipid
concentrations over the range studied, and glutamine
concentration showed a strong interaction with EAA.
The optimal concentrations of the variables studied
were 2.5 mM Glutamine, 7.4 mM (2·) EAA, 1.4 mM
(0.5·) NEAA, 1· ITS supplement, 0.7· Lipids
supplement. The maximum viable cell density
attained in the optimized medium was 1.4 · 106
cells/ml, a 35% improvement over the control
culture, while the final antibody titer attained was
22 ± 3.4 mg/mL, a 50% improvement.
Keywords Response surface method  Media
optimization
Introduction
Botulinum neurotoxin, produced by the anaerobic
Clostridium botulinum, is one of the most potent
toxins known to humans (Franz et al. 1997; Gill
1982). Clostridium botulinum produces seven anti-
genically distinct neurotoxins (A–G) differentiated
serologically by specific neutralization (Hatheway
1990). The active neurotoxin is synthesized as two
polypeptide chains, a heavy chain (100 KDa) and a
light chain (50 KDa), connected via disulfide linkage
(DasGupta and Sathyamoorthy 1984; Syuto and
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Kubo 1981). Recombinant monoclonal antibodies
(mAb) can neutralize the effects of BoNT A without
requiring human donors for plasmapheresis (Lang
et al. 1993). Potent neutralizing monoclonal antibod-
ies were identified recently, characterized, cloned and
expressed in Chinese Hamster Ovary (CHO) cells to
yield humanized mAbs (Nowakowski et al. 2002).
The large-scale, commercial production of thera-
peutically important proteins from rCHO cells
typically involves a suspension culture-based manu-
facturing process (Sinacore et al. 1996). It is desirable
to use serum-free medium in suspension culture
because serum can cause problems in subsequent
processes (Glassy et al. 1988; Keen and Rapson
1995). However, there is no universal serum-free
medium applicable to all cell lines. There is need to
develop specific medium suitable for each cell line
(Hayter et al. 1991; Zang et al. 1995).
The medium used for animal cell culture is very
complex. Further, as the impact of medium compo-
nents on cell growth or product synthesis is rather
difficult to fully elucidate, statistical methods are
adopted to develop a medium for cell culture that
offers optimal viable cell density and product forma-
tion. The traditional one-factor-at-a-time approach
to optimization is time-consuming and incapable of
reaching the true optimum especially because of
interactions among the factors that influence the
growth process. Moreover, this approach assumes
that the various growth parameters do not interact and
the process response is a direct function of a single
varied parameter (Castro et al. 1992; Freshney 1994).
In reality, the observed behavior of growth results
from the interactive influences of the various vari-
ables (Chen et al. 2002). To be effective, optimization
requires statistical methods that take these interac-
tions into account.
Response surface methodology (RSM), an exper-
imental strategy for seeking the optimum conditions
for a multivariable system, is a much more efficient
technique for optimization (Box et al. 1978). RSM
comprises of mathematical and statistical procedures
that can be used to study relationships between one or
more responses and a number of independent vari-
ables. In addition to analyzing the effects of inde-
pendent variables, this experimental methodology
generates a mathematical model that accurately
describes the overall process (Myers and Montgom-
ery 1995; Senanayake and Shahidi 2002). RSM has
been employed to solve multivariate problems and
optimize responses in many types of experiments
(Maddox and Richert 1977; Giovanni 1983; Houng
et al. 1989). In this approach, concentrations of
medium components are the variables; each variable
refers to some base value and varies in a certain
pattern. This pattern is designed by using statistical
methods to yield the most information by a minimum
number of experiments.
In this study, we have adopted a RSM approach to
locate the optimum levels of Glutamine, Essential
Amino Acids (EAA), Non-Essential Amino Acids
(NEAA), Insulin, Transferrin, Selenium (ITS), and
Lipids. Our objective is to gain insight into the
interactions among these factors that significantly
impact the response and viable cell density. Gluta-
mine acts as the primary source of nitrogen as well as
an additional carbon and energy source. It contributes
precursors to the formation of the major intracellular
binding blocks: amino acids, proteins. Approximately
30–65% of the cell energy requirement is derived
from glutamine metabolism (Zielke et al. 1984;
Reitzer et al. 1979). Amino acids are primary sources
of nitrogen that protect cells from nutrient depriva-
tion (Franek and Sramkova 1996), elevated osmolar-
ity (Øyaas et al. 1994) and elevated pCO2 (de
Zengotitia et al. 2002). Insulin serves as a growth and
maintenance factor and is considered to be important
for serum-free cultures (Schubert 1979). Insulin
stimulates uridine and glucose uptake and synthesis
of RNA, proteins and lipids; it also increases fatty
acid and glycogen synthesis (Mather and Sato 1979).
Transferrin is one of the most essential growth-
promoting supplements in serum-free medium, and
its omission causes severe inhibition of cell growth
(Kovar and Franek 1984). Transferrin is an iron
binding glycoprotein that interacts with surface
receptors. It is closely related to the transport of iron
across the plasma membrane (Bretscher 1985).
Transferrin has additional in-vitro functions, e.g.,
chelation of deleterious trace materials, that are
unlikely replaced by other components. Selenium is
a trace element essential for mammalian cell cultures
(Nielsen et al. 1981); its mechanism is poorly
understood. There is evidence that selenium enhances
growth rate in serum free-cultures (Darfler and Insel
1983). Lipids are required for proliferation, differen-
tiation, and antibody secretion. They play a major
role in the cell membrane which is composed of a
58 Cytotechnology (2007) 54:57–68
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phospholipid bilayer, and help in the transmission
of nutrients into the cell and excretion of proteins
out the cell (Farrant et al. 1984). The major
functions exhibited by the variables motivated us to
choose the response surface methodology in order to
observe the higher order interactions that would
maximize the response. Results were analyzed sta-
tistically by SAS and optimum conditions were
selected graphically. Interactions among these factors
were also examined.
Materials and methods
Cell line and medium
CHO-DG44 cells, which are dhfr negative, were
obtained as a gift from Dr. Larry Chasin (Columbia
University). The parental cell line was obtained by
weaning CHO-DG44 from the serum according to
standard cell culture techniques. The base medium
used during the weaning process was a commercial
serum-free medium, CHO-S-SFMII, known to con-
tain animal-derived proteins and hydrolysates. The
process of weaning CHO-DG44 of its serum depen-
dence lasted approximately 4–5 months. The result-
ing cell line was used as the starting point for all
subsequent development efforts including recombi-
nant cell line generation, medium development
studies. The recombinant cell line was constructed
by inserting the chimeric light and heavy chain IgG
genes against BoNT serotype A, along with the gene
for dhfr into the plasmid pcDNA3.1(+) (Invitrogen,
Carlsbad/CA) and the procedures are detailed else-
where (Mowry et al. 2004). Recombinant cell lines
were derived from our parent cell line using standard
molecular biology techniques.
Medium
The basal medium was prepared similar to the
HAM’s F12: IMDM (1:1) medium excluding Hypo-
xanthine and Thymidine, by adding components
separately. The concentration of the inorganic salts
and other components such as linoleic acid, lipoic
acid, phenol red, putrescine 2HCl, sodium pyruvate,
and HEPES is the same as with HAM’s F12:IMDM
(1:1). The concentrations of the glucose and gluta-
mine in the starting basal medium were 4 g/L and
4 mM, respectively. For amino acids the medium was
supplemented with 1.75· of EAA and 1.75· of
NEAA, which come from Gibco as 50· and 100·
solutions respectively. The concentrations of individ-
ual amino acids in EAA (50·) and NEAA (100·)
solutions are given in Table 1. The additional
components added to the basal medium are vitamins,
the concentrations of which were double those in
HAM’s F12:IMDM (1:1), 1· (ITS), and 0.7· Lipids
Supplement, which come as 100· solutions from
Gibco. The concentration of the individual compo-
nents in ITS and Lipids Supplements are given in the
Table 1. The composition of the complete basal
medium is given in Table 2.
Table 1 Composition of the individual components in mg/L in the solutions EAA, NEAA, ITS, Lipids, concentrated solutions from
Gibco
(50·) EAA [mg/L] (100·) NEAA [mg/L] (100·) ITS [mg/L] (100·) Lipids [mg/L]
L-Arginine [6320] L-Alanine [890] Insulin [1000] Arachidonic acid [2]
L-Cystine[1200] L-Asparagine[1320] Transferrin [0.67] Cholestrol [220]
L-Histidine · HCl · H2O [2100] L-Aspartic acid [1330] Selenium [0.55] DL-alpha-tocopherol-acetate [70]
L-Isoleucine [2620] L-Glutamic acid [1470] Linoleic acid [10]
L-Leucine [2620] Glycine [750] Linolenic acid [10]
L-Lysine HCl [3625] L-Proline [1150] Myristic acid [10]
L-Methionine [755] L-serine [1050] Oleic acid [10]
L-Phenylalanine [1650] Palitoelic acid [10]
L-Threonine [2380] Palmitic acid [10]
L-Tryptophan [510] Pluronic [0.1%]
L-Tyrosine [1800] Stearic acid [10]
L-Valine [2340] Tween 80 [2200]
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Cell culture
The cell cultivation was performed in 378C humid-
ified incubators supplemented with 5% carbon diox-
ide. The seeding density was 2 · 105 cells/mL, and
cell counts were performed every 4 days. The number
of cells were determined using a hemocytometer.
Spheroids would be enzymatically dissociated when
spherical aggregates were observed. Approximately,
1.7 mL of sample were harvested from spinners and
placed in a 2.0 mL microtube and centrifuged at
1,200 rpm for 6 min; 1.5 mL supernatant was saved
for antibody assays. Hundred microliters (mL) of
trypsin solution (2.5% (w/v) Trypsin in PBS) was
added to resuspend the cells of 400 ml. The cells were
incubated at room temperature for 15 min and the cell
density and viability were then determined by the
trypan blue exclusion method.
Antibody assay
The concentration of the whole antibody, as well as
the concentration of the light and heavy chain
portions, was determined by an enzyme-linked
Table 2 Concentrations of
the components in the
control medium
Components Composition
[mg/mL]
Components
(contd.)
Composition
[mg/mL]
CaCl2 (anhyd.) 99.1 L-Phenylalanine 57.7
CuSO4 · 5H2O 0.00125 L-Proline 20.12
FeSO4 · 7H2O 0.415 L-Serine 18.37
KCl 276.8 L-Threonine 83.3
MgCl2 (anhyd.) 28.61 L-Tryptophan 17.8
NaCl 5500 L-Tyrosine · 2Na · 2H2O 63
NaHCO3 2100 L-Valine 81.9
Na2HPO4 (anhyd.) 71 Biotin 0.02
Na2HPO4 · H2O 62.5 D-Ca Pantothenate 4
ZnSO4 · 7H2O 0.43 Choline chloride 18
KNO3 0.038 Folic acid 4
MgSO4 (anhyd.) 50.8 i-Inositol 25.2
Na2SeO3 0.0085 Niacinamide 4
D-glucose 4000 Pyridoxine HCl 4
Linoleic acid 0.04 Riboflavin 0.4
Lipoic acid 0.105 Thiamine HCl 4
Phenol Red 8.1 Vitamin B12 1.413
Putrescine 2HCl 0.0805 Insulin 10
Sodium pyruvate 110 Transferrin 5.5
HEPES 2979 Sodium selenite 0.0134
L-Alanine 15.57 Arachidonic acid 0.014
L-Arginine · HCl 221.2 Cholesterol 1.54
L-Asparagine · H2O 23.1 DL-alpha-tocopherol-acetate 0.49
L-Aspartic acid 23.27 Linoleic acid 0.07
L-Cystine · 2HCl 42 Linolenic acid 0.07
L-Glutamic acid 25.72 Myristic acid 0.07
L-Glutamine 584 Oleic acid 0.07
Glycine 13.12 Palitoelic acid 0.07
L-Histidine · HCl · H2O 73.5 Palmitic acid 0.07
L-Isoleucine 91.7 Stearic acid 0.07
L-Leucine 91.7 Tween 80 15.4
L-Lysine · HCl 126.88 Pluronic 0.10%
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immunosorbent assay. Affinity purified rabbit anti-
human IgG antibodies were diluted to 5 mg/mL in a
coating buffer consisting of 100 mM NaHCO3 and
100 mM NaCl (pH = 9.3). About 100 mL diluted
antibody was added to 96 well plates (Nunc)
and incubated overnight at 48C. The plates were
washed twice in a Tris buffer (20 mM Tris–HCl,
50 mM NaCl, pH = 7.2) containing 0.1% Tween 20,
and washed twice in the Tris buffer alone. Blocking
buffer (Tris buffer with 0.5% BSA) was added to the
96 well plates and incubated at 378C for 1 h.
Supernatant samples were diluted in the blocking
buffer and samples were loaded into the 96 well
plates in triplicate. Plates were incubated for 1 h at
378C and the washing procedure was repeated.
Hundred microliters (mL) of a goat anti-human IgG-
HRP conjugate antibody diluted to 0.5–2 mg/mL in
the dilution buffer was added to the plates. The plates
were incubated for 1 h at 378C and the washing
procedure was repeated. Finally, 100 mL of 50 mg/
mL ABTS in ABTS buffer (Roche) was added to the
plates. The absorbance was determined at 405 nm
using an ELx800 plate reader (Bio-Tek). This proce-
dure was used for the whole antibody, the heavy
chain (Fc specific), and the light chain (j specific). In
sandwich ELISA assays, rabbit anti-human IgG
antibodies raised against the whole molecule, Fab-
specific and kappa-chain specific, respectively, were
used to coat the ELISA plates. HRP-conjugated
rabbit anti-human IgG antibodies raised against the
whole molecule, Fab-specific and kappa-chain spe-
cific, respectively, were used in the detection step of
the ELISA assays.
Experimental design
Response surface methodology (RSM) was used to
determine the influence of some medium components
on the response of viable cell density. Our assump-
tion is that since our product is growth-associated,
increase in viable cell density will ultimately increase
the antibody production. Theoretical and fundamental
aspects of RSM have been extensively discussed
elsewhere (Myers and Montgomery 1995). The
experimental design adopted Box’s central compos-
ite design for five variables at five levels each. The
five independent variables were X1 = Glutamine,
X2 = EAA, X3 = NEAA, X4 = ITS, X5 = Lipids. The
independent variable coded regions were a (2,
Lowest Level), 1, 0 (middle level), 1, and +a (2,
highest level). The actual values, which were chosen
from preliminary studies, and the corresponding
coded and uncoded values of the five independent
variables are given in Table 3. The complete design
has 42 experimental points, which including eight
replications of the center point. The treatment
combinations and observed responses are presented
in Table 4. The 50 experimental medium runs were
prepared in random order and the experiments
were performed in four batches. The dependent
variable (Y) was viable cell density and was assumed
to be affected by the five independent variables.
Based on data from this design, we fit a second order
or higher order polynomial regression model de-
scribed as follows:
Y ¼ bl þ
Xk
i¼1
biXi þ
Xk
i¼1
biiX
2
i þ
X
i
X
j
bijXiXj þ 
where
Y = Viable cell density
bl = Intercept for block l
X = Factors (X1 = Glutamine, X2 = EAA,
X3 = NEAA, X4 = ITS, X5 = Lipids)
bz = Regression coefficient (z = i, ii or ij, where
i < j)
e = Residual error
k = 1,2,3…
Statistical analysis
Using ordinary least squares the regression model
was fit to evaluate, the explanatory variables regard-
ing linear, interaction, and quadratic effects of coded
Table 3 Actual factor levels corresponding to coded factor
levels
Level Symbol Actual factor level at coded factor
level of
2 1 0 1 2
Glutamine X1 1 mM 2.5 mM 4 mM 5.5 mM 7 mM
EAA X2 0· 0.5· 1· 1.5· 2·
NEAA X3 0.25· 1· 1.75· 2.5· 3.25·
ITS X4 0.25· 1· 1.75· 2.5· 3.25·
LIPIDS X5 0.1· 0.4· 0.7· 1· 1.3·
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levels of Glutamine, EAA, NEAA, ITS, Lipids on
cell density. The R2 value was used to evaluate model
sufficiency and the a-level was set as 5%, at which
point every term in the selected model should be
significant. The reduced model was evaluated using
the R2. Lack of fit was used to attempt to find optimal
conditions for all the variables maximizing the cell
density. Canonical analysis was then used to evaluate
the nature of the stationary point (maximum, mini-
mum or saddle) and to find the ridge of steepest
ascent. Further experiments were carried out in the
direction of the maximum response along with
alternate experiments where Glutamine was set to
different coded levels from ‘0’ to ‘3’, keeping EAA
constant at coded level ‘2’ and ‘4’. All statistical
computations were done using SAS/STAT proce-
dures, and optimum conditions were found through
SAS data-step programming. Response surface plots
were generated by SAS/GRAPH.
Results and discussion
Regression analysis revealed that linear (Xi) and
quadratic effects (Xi · Xi) were more significant than
cross product interactions (Xi · Xj), as based on the p-
values obtained (Table 5). Among all independent
variables, Glutamine (negative effect, X1: 2.79) and
NEAA (positive effect, X3: 3.07) had the greatest
effects on the cell density, while EAA showed an
effect when combined with Glutamine (X2 · X1).
Among the pairwise interactions, EAA and Gluta-
mine exhibited the greatest effect. Although NEAA
squared (X3 · X3) and NEAA (X3) by itself were
significant, they did not have a great effect when
Table 4 Treatment combinations with variables in coded
values and the values of response
Run X1 X2 X3 X4 X5 Y
1 1 1 1 1 1 8.1E + 05
2 1 1 1 1 1 7.2E + 05
3 1 1 1 1 1 6.5E + 05
4 0 0 0 2 0 8.3E + 05
5 1 1 1 1 1 1.0E + 06
6 1 1 1 1 1 8.0E + 05
7 2 0 0 0 0 7.3E + 05
8 0 0 0 0 2 7.1E + 05
9 1 1 1 1 1 5.4E + 05
10 0 0 0 0 0 9.5E + 05
11 1 1 1 1 1 6.6E + 05
12 0 0 0 0 0 9.3E + 05
13 1 1 1 1 1 8.40E + 05
14 1 1 1 1 1 8.80E + 05
15 1 1 1 1 1 6.25E + 05
16 1 1 1 1 1 7.00E + 05
17 0 0 0 0 0 1.18E + 06
18 1 1 1 1 1 8.15E + 05
19 0 0 0 0 2 1.15E + 06
20 1 1 1 1 1 6.55E + 05
21 0 0 0 0 0 1.16E + 06
22 1 1 1 1 1 2.00E + 05
23 2 0 0 0 0 1.52E + 06
24 0 0 0 2 0 5.15E + 05
25 0 2 0 0 0 3.10E + 05
26 1 1 1 1 1 8.20E + 05
27 1 1 1 1 1 5.10E + 05
28 1 1 1 1 1 8.10E + 05
29 1 1 1 1 1 7.85E + 05
30 0 0 0 0 0 1.18E + 06
31 1 1 1 1 1 8.30E + 05
32 0 0 2 0 0 9.55E + 05
33 1 1 1 1 1 1.29E + 06
34 0 0 2 0 0 1.80E + 05
35 1 1 1 1 1 2.00E + 05
36 1 1 1 1 1 2.20E + 05
37 0 0 0 0 0 1.21E + 06
38 1 1 1 1 1 1.03E + 06
39 1 1 1 1 1 9.00E + 05
40 1 1 1 1 1 9.85E + 05
41 1 1 1 1 1 8.65E + 05
42 1 1 1 1 1 8.75E + 05
43 1 1 1 1 1 7.70E + 05
Table 4 continued
Run X1 X2 X3 X4 X5 Y
44 1 1 1 1 1 1.08E + 06
45 0 0 0 0 0 9.90E + 05
46 1 1 1 1 1 9.35E + 05
47 1 1 1 1 1 8.55E + 05
48 1 1 1 1 1 1.00E + 06
49 0 2 0 0 0 8.90E + 05
50 0 0 0 0 0 9.85E + 05
Where a = ‘2’, Response (Y) = Viable cell density in cells/
mL, ‘1’, ‘0’, ‘+1’ are coded factorial levels
62 Cytotechnology (2007) 54:57–68
123
compared with the other variables, as judged by the
p-value. The response surface plots were then plotted
to see the effect of EAA and NEAA (Fig. 1), EAA
and Glutamine (Fig. 2), NEAA and Glutamine
(Fig. 3) on the response which is the viable cell
density (Y). ITS and Lipids were found to have no
effect. The R2 value for the total model is 0.6339. To
simplify the model, the variables of ITS and Lipids
were removed from the model and the data were re-
analyzed using the reduced model. The polynomial
regression model used for three variables was
Y ¼bo þ b1X1 þ b2X2 þ b3X3 þ b11X211 þ b22X22
þ b33X23 þ b12X1X2 þ b13X1X3 þ b23X2X3 þ 
When the variables ITS and Lipids were kept
constant, the lack of fit is found to be insignificant,
suggesting that the model was adequate to explain the
effect of these three variables on the response. The R2
value of the reduced model decreases to 0.502, as
denoted in Table 6. As Table 6 shows, the Glutamine
(X1) had significant linear effects and interacted with
EAA (X2). EAA and NEAA had significant quadratic
effects (X2 · X2 and X3 · X3) while NEAA (X3) also
had a linear effect on the cell density.
Canonical analysis
Canonical analysis is a mathematical approach used
to examine the overall shape of the response surface
and to determine if the estimated response point is a
maximum, minimum or a saddle point. If the
stationary point is maximum or minimum, a corre-
sponding increase or decrease will result in the
response. In the case of a saddle point, the response
may increase or decrease when we move away from
Table 5 The t- and p- values of full model with X1, X2, X3,
X4, X5 as independent variables
Parameter t-value p-value
Intercept 13.75 <0.001
X1 2.79 0.0092
X2 1.53 0.1376
X3 3.07 0.0046
X4 1.2 0.2404
X5 0.81 0.425
X1 · X1 0.66 0.5167
X2 · X1 2.1 0.1446
X2 · X2 2.67 0.0124
X3 · X1 0.27 0.7855
X3 · X2 0.1 0.9206
X3 · X3 2.86 0.0078
X4 · X1 0.31 0.758
X4 · X2 0.22 0.8304
X4 · X3 0.74 0.4662
X4 · X4 2.21 0.0352
X5 · X1 0.8 0.4292
X5 · X2 1.3 0.2026
X5 · X3 0.25 0.8061
X5 · X4 0.2 0.8427
X5 · X5 0.58 0.5675
Linear 0.0046
Quadratic 0.0055
Cross Product 0.6621
R2 = 0.6339 for the total model
-2.00
0.67
2.00
NEAA
-2.00
Response
221863
516730
811597
1106465
-0.67
-0.67
0.67
2.00
EAA
Fig. 1 Response surface
plot showing the effect of
EAA, NEAA, and their
mutual effect on the
response (viable cell
density). Other variables
were held at zero level
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the stationary point, depending on which direction is
taken. Maximizing the viable cell density is of
interest; however the stationary point was a saddle
point, so we move on the ridge in the direction to get
the maximum response.
The points on the ridge that increased the response
were found using the RIDGEMAX option of the
SAS/RSREG procedure, and are shown in Table 7.
From Tables 6 and 7, glutamine showed a negative
effect on cell density while EAA, NEAA showed a
positive effect. Therefore the glutamine values for the
ridge moved in the negative direction and the values
for EAA and NEAA moved in the positive direction.
Following the ridge in Table 7, the highest cell
density was 1.37E + 06 cells/mL, but this prediction
was not very reliable due to a large standard error
obtained (144554). Based on the ridge analysis, the
glutamine concentrations at high cell densities were
found to decreasing, to a level of 1 mM or lower.
Glutamine values smaller than 1 mM were thought to
-2.00
-0.67
0.67
2.00
Glutamine
-2.00
-0.67
0.67
2.00
EAA
Response
325416
660443
995469
1330495
Fig. 2 Response surface
plot showing the effect of
EAA, glutamine and their
mutual effect on the
response (viable cell
density). Other variables
were held at zero level
-2.00
0.67
2.00
-2.00
-0.67
0.67
2.00
NEAA
Response
471620
825403
1179185
-0.67 Glutamine117838
Fig. 3 Response surface
plot showing the effect of
NEAA, glutamine and their
mutual effect on the
response (viable cell
density). Other variables
were held at zero level
Table 6 The t- and p- values of the reduced model with X1,
X2, X3 as independent variables
Parameter t-value p-value
Intercept 15.56 <0.0001
X1 2.81 0.0076
X2 1.54 0.132
X3 3.1 0.0036
X1 · X1 0.66 0.5123
X2 · X1 2.11 0.0407
X2 · X2 2.69 0.0105
X3 · X1 0.28 0.7835
X3 · X2 0.1 0.9199
X3 · X3 2.88 0.0064
Linear 0.001
Quadratic 0.0035
Cross product 0.2242
R2 = 0.5022 for the reduced model
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be unreasonable and therefore additional experiments
were conducted on the ridge below glutamine values
of 1 mM.
To further explore the surface, we used the
reduced model from Table 7, and obtained predicted
cell densities at constant glutamine concentrations at
different coded levels from ‘0’ to ‘3’, NEAA at
‘0.5’ and various values of EAA. The results are
shown in Table 8. The results suggest that cell density
increases as EAA (X2) increases when glutamine
values are low. Figure 4 shows the effect of EAA and
NEAA on VCD when glutamine is controlled at
coded level ‘1’.
EAA values up to a coded level of 14.5 (uncoded
value = 12.625 X) are unfeasible because of osmotic
effects or inhibition of metabolic pathways due to
overfeeding the nutrients. According to the above
results, however, it appears that with reduced Gluta-
mine levels and concentrations of EAA and NEAA at
a 0.5 coded level, large cell densities could possibly
be obtained.
Alternate experiments
To further evaluate the surface we ran some alternate
experiments at different levels of glutamine (from
coded level ‘0’ to’ 3’), keeping EAA constant at
coded levels 2 and 4. We expected low cell growth at
a glutamine value less than ‘1.5 coded level’ and no
cell growth at zero (‘2’ coded level) glutamine
concentration. We also expected the EAA coded level
of ‘2’ to result in higher cell densities compared to
EAA coded level ‘4,’ due to osmotic effects and the
inhibition of metabolic pathways from overfeeding.
Therefore 14 additional experiments were conducted,
four on the ridge, four at different levels of Glutamine
keeping EAA at coded level ‘2,’ four at EAA coded
level ‘4,’ and two controls (basal medium) as shown
in Table 9.
These experiments were conducted under the same
conditions as the initial experiments. The starting
density of the cultures was 2 · 105 cells/mL, and the
cells were allowed to adapt to the medium in four
passages. The final viable cell densities were derived
as an average of the third and the fourth passage, as
shown in Table 9.
Medium-6 had a higher cell density compared to
the controls (13 and 14), but the last passage of
medium 3, 9, and 5 were nearly equal to the control
medium, as shown in Fig. 5. Media which had results
equivalent to, or better than medium-0, were carried
out for one more passage (up to 8 days), to validate
the data. The results are shown in Fig. 6. From
passage 5, the viable cell density attained in medium
6 after 5 days of culture was about 1.6 times higher
than the control.
Replicate experiments
To validate the above results, the cells in the control
medium were taken out of a frozen state, and the
experiment was repeated three times with control
medium and medium-6. Cells were allowed to go for
four passages and the final viable cell densities were
taken as an average of passage 3 and passage 4. The
results are presented in Fig. 7.
In medium-6, a viable cell density of 1.45 ·
106 cells/mL was attained, which was found to be 1.4
times higher than for the control medium and within
two standard errors of 1.23E + 06 from the original
run of medium 6 (standard error = 215,928 cells/mL
Table 7 Ridge of steepest ascent for X1, X2, X3 independent
variables, and estimated response and standard error
X1 X2 X3 Estimated cell
density (105)
SE
0.15 0.07 0.11 10.1 62346
0.33 0.13 0.18 10.4 61381
0.52 0.20 0.23 10.7 60421
0.71 0.26 0.26 11.0 60558
0.91 0.32 0.28 11.4 63278
1.10 0.38 0.30 11.8 70025
1.29 0.43 0.31 12.2 81626
1.49 0.49 0.33 12.7 98153
1.68 0.55 0.34 13.2 119266
1.87 0.60 0.35 13.7 144554
Table 8 Effect on EAA, NEAA and VCD when glutamine is
controlled at different coded levels
X1(level) X2(Level) X3(Level) VCD
0.5 4.5 0.5 1.27E + 06
1 6.5 0.5 1.56E + 06
1.5 8.5 0.5 1.95E + 06
2 10.5 0.5 2.43E + 06
2.5 12.5 0.5 3.01E + 06
3 14.5 0.5 3.69E + 06
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for medium 6). After four passages, if the cells were
allowed to grow to passages of 5–7 the viable cell
density obtained in medium-6 increased to
1.6 · 106 cells/ml. The viable cell density in the
control experiment in these passages (passages 5–7)
was between 9.2 · 105 cells/mL and 1.1 · 106 cells/
mL, with in the standard deviation of 128,103 cells/
mL (data not shown).
Assuming the specific antibody production (mg
protein per cell per day) depends on the cell density,
we expect to see an increase in the specific antibody
production with an increase in the cell density. As
detailed in the methods section, transformed cells
were cultured in control and the optimized medium,
medium-6, and the antibody titer was estimated in the
supernatant, the specific antibody production was
determined. Standard deviation was calculated in
these media from triplicate experiments. The results
are shown in Fig. 8. The antibody titer was
determined for all the initial medium (*50) exper-
iments, and the results were analyzed using SAS/
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Fig. 4 Response surface
plot showing the effect of
EAA (X2), NEAA (X3) and
their mutual effect on the Y
(viable cell density), when
glutamine (X1) is controlled
at 1 coded level
Table 9 Alternate experiments carried out on ridge and glu-
tamine controlled at different coded levels, keeping EAA
constant at coded levels 2 and 4
Medium X1 X2 X3 VCD (105) SD
1 0.52 0.196 0.225 8.13 203490
2 1.1 0.375 0.299 8.81 179368
3 1.487 0.491 0.329 8.61 60052
4 1.874 0.604 0.352 8.01 152664
5 0 2 0.5 9.35 42230
6 1 2 0.5 1.23 215928
7 2 2 0.5 7.23 277564
8 3 2 0.5 1.79 45162
9 0 4 0.5 7.93 102429
10 1 4 0.5 4.49 152555
11 2 4 0.5 5.7 144684
12 3 4 0.5 2 52915
13 0 0 0 9.15 134722
14 0 0 0 9.48 121484
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Fig. 5 Viable cell density versus medium number tested. The
plot shows the viable density obtained in the last passage
(passage 4) of alternate experiments undertaken. Details on
media are listed in Table 9
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STAT procedures. We observed the same trend for
antibody production as well, where the stationary
point is a saddle point, and the ridge values for the
glutamine were moving in the negative direction and
in positive direction for EAA and NEAA, shown in
Table 10. The R2 value for the model was 0.75 which
shows adequacy of the model in explaining the effect
of the variables on the response which is antibody
production. Thus the antibody titer in medium-6 was
estimated to be 1.6 times higher than the control
medium and the composition of the variables in
medium-6, that was found to be optimal in our
present study, is listed is Table 11.
Conclusions
The increase in the Viable cell density (Cells/mL),
and the production of the antibody against BoNT-A
was accomplished by using Box-Wilson’s Central
Composite Design.
In the optimal media, a 1.4 times higher in the
viable cell density and a 1.6 times higher found
antibody titer was obtained. Lower levels of glutamine
and higher levels of EAA are preferred. From the
results presented here, we expect that one of the amino
acids is replacing the role of amino acid-glutamine,
and may be acting as limiting nutrient. Thus in our
future and ongoing efforts, we will undertake amino
acid analysis, to identify the limiting amino acid. We
speculate that the addition of the limiting amino acid,
albeit separately, separately, a decrease in the concen-
tration of the total amino acid can be engineered, thus
make the medium more economical. We also antici-
pate increased cell densities and higher antibody titers.
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